SKYE
Skye Bioscience
$0.62
−$0.03 (−4.45%)Jul 27, 2026
Key metrics
The numbers that frame SKYE today
- Market cap
- $21.89M
- P/E (TTM)
- -0.4
- EV / FCF
- -0.3
- ROIC
- -450.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.57
- 52wk High
- $4.99
Growth
Revenue and earnings trend for SKYE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SKYE
Is Skye Bioscience a good buy?
No. Skye Bioscience has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Skye Bioscience is selling at a very high price.
What is the market capitalization of SKYE?
Skye Bioscience's market capitalization is $21.89M.
What is the P/E ratio for SKYE stock?
Skye Bioscience's current P/E ratio is -0.4.
What is the 52-week high for SKYE stock?
The 52-week high for Skye Bioscience is $4.99. The current close of $0.62 is 87.5% below that high.
What is the 52-week low for SKYE stock?
The 52-week low for Skye Bioscience is $0.57. The current close of $0.62 is 10.1% above that low.
Does SKYE stock pay dividends?
Skye Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SKYE?
Skye Bioscience's Debt / Equity ratio is 0.04.